My WebLink
|
Help
|
About
|
Sign Out
Home
2025-03-09 Sherilyn Wells
PublicDocuments
>
Planning Department
>
Leeward/Windward Planning Commission
>
Board Packets
>
2025
>
2025-03-10 - Windward Continuance of Special General Plan Meeting
>
Info Given at 3-10-25 Meeting (9)
>
2025-03-09 Sherilyn Wells
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
3/10/2025 4:18:33 PM
Creation date
3/10/2025 4:17:39 PM
Metadata
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
90
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
Show annotations
View images
View plain text
M•CAM <br /> INTERNATIONAL <br /> US20060093616 Process for vaccinating eucaryotic hosts and for protecting against SARS- 29-Sep-04 <br /> 4-May-06 CoV infection LTMEYER RALF 28-Sep-054-May-06 <br /> N-Nov-05 <br /> -Nov-03 <br /> US20050249739 Antibodies against SARS-CoV and methods of use thereof MARASCO WAYNE -Nov-04 <br /> ]0-Nov-05 <br /> 10-Mar-04 <br /> US20050203038 Modulation of ACE2 expression 10-Mar-04 <br /> 15-Sep-05 <br /> �15-Sep-05 <br /> 15-Sep-03 <br /> US20050113298 <br /> 26-May Receptor binding peptides derived from the SARS S protein 13-Sep-04 <br /> �26-May-05 <br /> US20050112554 Characterization of the earliest stages of the severe acute respiratory 9-Jul-04 <br /> 26-May-05 syndrome (SARS) virus and uses thereof HENG XU RUI 9-Jul-0426-May-05 <br /> i i i f i h i l l l i ctve ow molecular weight variants o angotensn converting enzyme 2 24-Jan-17 <br /> US10443049 A (Northwestern University 1115-Oct-19 <br /> 24-Jan-18 <br /> (ACE2) <br /> The United States of America, as 24-Feb-15 <br /> FS10301377 Middle east respiratory syndrome coronavirus immunogens, antibodies, Represented by the Secretary, 24-Feb-16 <br /> and their use Department of Health and Human 28-May-19 <br /> Services <br /> Middle east respiratory syndrome coronavirus neutralizing antibodies and DANA-FARBER CANCER INSTITUTE, 25-Apr-14 <br /> US10131704 p y y g(methods of use thereof INC. 27-Apr-1520-Nov-18 <br /> ANIMATE VALUE TM <br /> Info@m-cam.com 513 E Main Street #2014 Charlottesville, VA 22902 T: 434.979•7240 <br />
The URL can be used to link to this page
Your browser does not support the video tag.